Your browser doesn't support javascript.
loading
A Grant-Based Experiment to Train Clinical Investigators: The AACR/ASCO Methods in Clinical Cancer Research Workshop.
Von Hoff, Daniel D; Clark, Gary M; Coltman, Charles A; Disis, Mary L; Eckhardt, S G; Ellis, Lee M; Foti, Margaret; Garrett-Mayer, Elizabeth; Gönen, Mithat; Hidalgo, Manuel; Hilsenbeck, Susan G; Littlefield, John H; LoRusso, Patricia M; Lyerly, H Kim; Meropol, Neal J; Patel, Jyoti D; Piantadosi, Steven; Post, Dean A; Regan, Meredith M; Shyr, Yu; Tempero, Margaret A; Tepper, Joel E; Von Roenn, Jamie; Weiner, Louis M; Young, Donn C; Vu, Nu V.
Affiliation
  • Von Hoff DD; Translational Genomics Research Institute, Phoenix, Arizona. dvh@tgen.org.
  • Clark GM; Gary Clark Statistical Consulting LLC, Superior, Colorado.
  • Disis ML; UW Medicine Cancer Vaccine Institute, University of Washington, Seattle, Washington.
  • Eckhardt SG; The University of Texas at Austin, Dell Medical School, Austin, Texas.
  • Ellis LM; The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Foti M; American Association for Cancer Research, Philadelphia, Pennsylvania.
  • Garrett-Mayer E; American Society of Clinical Oncology, Alexandria, Virginia.
  • Gönen M; Memorial Sloan Kettering Cancer Center, New York, New York.
  • Hidalgo M; Weill Cornell Medicine, New York Presbyterian Hospital, New York, New York.
  • Hilsenbeck SG; Dan L Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, Texas.
  • LoRusso PM; Yale University, Yale Cancer Center, New Haven, Connecticut.
  • Lyerly HK; Duke University, Durham, North Carolina.
  • Meropol NJ; Flatiron Health, New York, New York.
  • Patel JD; Case Comprehensive Cancer Center, Case Western Reserve University, Cleveland, Ohio.
  • Piantadosi S; Northwestern University, Chicago, Illinois.
  • Post DA; Department of Surgery, Brigham and Women's Hospital, Boston, Massachusetts.
  • Regan MM; American Association for Cancer Research, Philadelphia, Pennsylvania.
  • Shyr Y; Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Tempero MA; Vanderbilt University Medical Center, Nashville, Tennessee.
  • Tepper JE; University of California San Francisco Pancreas Center, San Francisco, California.
  • Von Roenn J; University of North Carolina at Chapel Hill, Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina.
  • Weiner LM; American Society of Clinical Oncology, Alexandria, Virginia.
  • Young DC; Georgetown Lombardi Comprehensive Cancer Center, Washington, D.C.
  • Vu NV; The Ohio State University Comprehensive Cancer Center, Columbus, Ohio.
Clin Cancer Res ; 27(20): 5472-5481, 2021 10 15.
Article in En | MEDLINE | ID: mdl-34312215
ABSTRACT
To address the need for clinical investigators in oncology, American Association for Cancer Research (AACR) and American Society for Clinical Oncology (ASCO) established the Methods in Clinical Cancer Research Workshop (MCCRW). The workshop's objectives were to (i) provide training in the methods, design, and conduct of clinical trials; (ii) ensure that clinical trials met federal and international ethical guidelines; (iii) evaluate the effectiveness of the workshop; and (iv) create networking opportunities for young investigators with mentoring senior faculty. Educational methods included (i) didactic lectures, (ii) Small Group Discussion Sessions, (iii) Protocol Development Groups, and (iv) one-on-one mentoring. Learning focused on the development of an Institutional Review Board (IRB)-ready protocol, which was submitted on the last day of the workshop. Evaluation methods included (i) pre- and postworkshop tests, (ii) students' workshop evaluations, (iii) faculty's ratings of protocol development, (iv) students' productivity in clinical research after the workshop, and (v) an independent assessment of the workshop. From 1996 to 2014, 1,932 students from diverse backgrounds attended the workshop. There was a significant improvement in the students' level of knowledge from the pre- to the postworkshop exams (P < 0.001). Across the classes, student evaluations were very favorable. At the end of the workshop, faculty rated 92% to 100% of the students' protocols as ready for IRB submission. Intermediate and long-term follow-ups indicated that more than 92% of students were actively involved in patient-related research, and 66% had implemented five or more protocols. This NCI-sponsored MCCRW has had a major impact on the training of clinicians in their ability to design and implement clinical trials in cancer research.
Subject(s)

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Research Personnel / Societies, Medical / Biomedical Research / Financing, Organized / Medical Oncology / Neoplasms Type of study: Guideline / Qualitative_research Aspects: Ethics Limits: Humans Country/Region as subject: America do norte Language: En Journal: Clin Cancer Res Journal subject: NEOPLASIAS Year: 2021 Document type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Research Personnel / Societies, Medical / Biomedical Research / Financing, Organized / Medical Oncology / Neoplasms Type of study: Guideline / Qualitative_research Aspects: Ethics Limits: Humans Country/Region as subject: America do norte Language: En Journal: Clin Cancer Res Journal subject: NEOPLASIAS Year: 2021 Document type: Article